Showing results (291-300 of 332) with videos related to
Sort By:
Pageof 34
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 YearsFernando Magro, Diogo Magalhães, Marta Patita, et al.Autoimmunity Reviews|December 21, 2023
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness studyVirginia Solitano, Paola Facheris, Magnus Petersen, et al.Journal of Crohn'S & Colitis|January 20, 2024
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease PatientsFernando Magro, Samuel Fernandes, Marta Patita, et al.Journal of Crohn'S & Colitis|June 21, 2011
Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom studyJohan Burisch, Silvija Cukovic-Cavka, Ioannis Kaimakliotis, et al.Ebiomedicine|June 21, 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic EscalationFernando Magro, Joana Afonso, Susana Lopes, et al.Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.Therapeutic Advances in Gastroenterology|August 5, 2026
IOIBD: the International Organization for the Study of Inflammatory Bowel DiseaseIris Dotan, Marla C Dubinsky, Corey A Siegel, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 29, 2026
Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJurij Hanzel, Yuhong Yuan, Shane W Goodwin, et al.Inflammatory Bowel Diseases|January 21, 2017
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling OutcomesFernando Magro, Cláudia C Dias, Rosa Coelho, et al.Pageof 34